Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Pascal Frankhauser"'
Autor:
Daniel Kopf, Claudia Schilling, Pascal Frankhauser, Bettina Weber-Hamann, Maria Gilles, Michael Deuschle, Florian Lederbogen, Vera Onken, Barbara Scharnholz
Publikováno v:
Psychiatry Research. 177:109-113
Lowering the concentrations of free cortisol in depressed patients may be an important prerequisite to prevent glucocorticoid-related sequelae of depression. We tested the hypothesis that the hypothalamus-pituitary-adrenal (HPA) system-dampening effe
Autor:
Michael Deuschle, Vera Onken, Bettina Weber-Hamann, Claudia Schilling, Maria Gilles, Florian Lederbogen, Pascal Frankhauser, Daniel Kopf
Publikováno v:
Journal of Clinical Psychopharmacology. 28:581-584
Autor:
Reka Baranyai, Florian Lederbogen, Patrick Schloss, Thorben Ahrens, Pascal Frankhauser, Michael Deuschle
Publikováno v:
Thrombosis and haemostasis. 100(6)
Platelet surface P-selectin expression is highly correlated with serotonin transporter density in human subjects
Autor:
Claudia Schilling, Vera Onken, Maria Gilles, Daniel Kopf, Benedikt Römer, Michael Deuschle, Bettina Hamann, Pascal Frankhauser, Florian Lederbogen, Sabina Lewicka
Publikováno v:
Neuroendocrinology. 90(3)
Background: Chronic stress as well as major depressive disorders are associated with hypercortisolemia and impaired hypothalamic-pituitary-adrenocortical axis functioning. The aim of this study was to determine whether in major depression changes in
Publikováno v:
Journal of clinical psychopharmacology. 27(6)
Objective Pharmacological treatment with selective serotonin reuptake inhibitors (SSRIs) is thought to decrease coronary risk in patients with depressive disorder. Selective serotonin reuptake inhibitor intake may (1) attenuate the hypothalamus-pitui
Autor:
Yvonne Grimmer, Pascal Frankhauser, Patrick Schloss, Peter Bugert, Martin H. Schmidt, Michael Deuschle
Publikováno v:
Neuroscience letters. 399(3)
Compelling evidence suggests a monoaminergic dysfunction in the aetiology of various neuro-psychiatric diseases such as depression, attention deficit hyperactivity disorder (ADHD), schizophrenia, addiction and Parkinson's disease. The efficiency of m